These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9822981)

  • 1. The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.
    Lindheim SR; Chang PL; Vidali A; Ferin M; Sauer MV
    J Assist Reprod Genet; 1998 Oct; 15(9):538-41. PubMed ID: 9822981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum inhibin levels and suppressed luteinizing hormone surge in young patients stimulated with gonadotropins.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Sztanyik L; Papp Z; Runnebaum B
    Gynecol Endocrinol; 1993 Mar; 7(1):23-31. PubMed ID: 8506760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
    J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
    Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T; Yamano S; Nishida S; Murayama S; Aono T
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and influence of an endogenous serum luteinizing hormone surge after ovulation induction in stimulated cycles.
    Kainz C; Reinthaller A; Schneider B; Fischl F; Bieglmayer C
    Gynecol Endocrinol; 1994 Dec; 8(4):227-32. PubMed ID: 7709761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome.
    Hughes EG; Robertson DM; Handelsman DJ; Hayward S; Healy DL; de Kretser DM
    J Clin Endocrinol Metab; 1990 Feb; 70(2):358-64. PubMed ID: 2298853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gonadotropin surge by a brief mid-cycle regimen of ethinyl estradiol and norethindrone: possible role in in vitro fertilization.
    Letterie GS
    Gynecol Endocrinol; 2000 Feb; 14(1):1-4. PubMed ID: 10813099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma inhibin A in heifers: relationship with follicle dynamics, gonadotropins, and steroids during the estrous cycle and after treatment with bovine follicular fluid.
    Bleach EC; Glencross RG; Feist SA; Groome NP; Knight PG
    Biol Reprod; 2001 Mar; 64(3):743-52. PubMed ID: 11207187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in plasma concentrations of gonadotropins, inhibin, estradiol-17beta and progesterone in cows with ultrasound-guided follicular aspiration.
    Tohei A; Shi FX; Ozawa M; Ima K; Takahashi H; Shimohira I; Kojima T; Watanabe G; Taya K
    J Vet Med Sci; 2001 Jan; 63(1):45-50. PubMed ID: 11217062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
    Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
    J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer.
    Yohkaichiya T; Polson DW; Hughes EG; MacLachlan V; Robertson DM; Healy DL; de Kretser DM
    Fertil Steril; 1993 May; 59(5):1081-9. PubMed ID: 8486178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
    Nilsson L; Wikland M; Hamberger L; Hillensjö T; Chari S; Sturm G; Daume E
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):17-22. PubMed ID: 3926921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.